A V Maksimenko
Overview
Explore the profile of A V Maksimenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maksimenko A, Vavaeva A, Zvyagintseva M, Abramov A, Timoshin A, Vavaev A, et al.
Biomed Khim
. 2016 Jul;
62(3):295-301.
PMID: 27420622
Previously it found that the bienzymatic conjugate superoxide dismutase-chondroitin sulfate, catalase (SOD-CHS-CAT) increased the survival rate of rats with endotoxic shock caused by the administration of lipopolysaccharide (LPS). This effect...
2.
Maksimenko A, Turashev A
Bioorg Khim
. 2015 Apr;
40(3):259-74.
PMID: 25898732
In normal state, a complex multicomponent system called glycocalyx is present on the surface of endothelial vascular system. Due to complexity of its composition and location on the border between...
3.
Maksimenko A, Turashev A
Bioorg Khim
. 2015 Apr;
40(2):131-41.
PMID: 25895332
In normal state, a complex multicomponent system called glycocalyx is present on the surface of endothelial vascular system. The structure of the glycocalyx is determined by a group ofproteoglycans, glycoproteins...
4.
Maksimenko A, Turashev A, Beabealashvili R
Biochemistry (Mosc)
. 2015 Mar;
80(3):284-95.
PMID: 25761683
A 3D-model of bovine testicular hyaluronidase (BTH) was constructed based on established tertiary structure of human hyaluronidase Hyal1 using a molecular homological modeling method in silico. The analysis of the...
5.
Maksimenko A
Biomed Khim
. 2015 Jan;
60(6):677-82.
PMID: 25552508
Physiological plasminogen activators of tissue and urokinase type (serine proteinases) are effective thrombolytic agents. Research and development of their novel forms contributed to progress of thrombolytic therapy, advanced treatment of...
6.
Zyuzkov G, Maksimenko A, Zhdanov V, Udut E, Turashev A, Miroshnichenko L, et al.
Bull Exp Biol Med
. 2014 Apr;
156(4):544-7.
PMID: 24771446
We have demonstrated the possibility of stimulation of the function of various types of precursor cells with hyaluronidase modified with chondroitin sulfate. Parenteral administration of modified hyaluronidase increased the number...
7.
Maksimenko A
Acta Naturae
. 2012 Nov;
4(3):72-81.
PMID: 23150805
The results of the clinical use of thrombolytic and antithrombotic preparations developed on the basis of protein conjugates obtained within the framework of the conception of drug targeting delivery in...
8.
Vavaev A, Buriachkivskaia L, Tishchenko E, Uchitel I, Maksimenko A
Biomed Khim
. 2012 Aug;
58(3):300-9.
PMID: 22856135
A covalent bienzyme superoxide dismutase-chondroitin sulfate-catalase conjugate (SOD-CHS-CAT) demonstrated the dose-dependent inhibitory action on induced aggregation of platelets in the presence of hydrogen peroxide. Antioxidant activity of SOD-CHS-CAT appeared at...
9.
Vavaev A, Buryachkovskaya L, Uchitel I, Tishchenko E, Maksimenko A
Bull Exp Biol Med
. 2012 Jul;
152(3):307-12.
PMID: 22803073
Effects of H(2)O(2) on platelet aggregation were estimated in vitro in the presence and absence of inductors (ADP, serotonin, TRAP) and native and modified catalase. Dose-dependent effect of H(2)O(2) (50...
10.
Maksimenko A, Vavaev A, Bouryachkovskaya L, Mokh V, Uchitel I, Lakomkin V, et al.
Acta Naturae
. 2012 Jun;
2(4):82-94.
PMID: 22649668
Bienzyme conjugate was obtained by the covalent connection of superoxide dismutase with catalase through endothelial glycocalyx glycosaminoglycan - chondroitin sulfate (SOD-CHS-CAT). This SOD-CHS-CAT conjugate has vasoprotective activity in respect to...